236 related articles for article (PubMed ID: 9303307)
1. The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry.
Huang DC; O'Reilly LA; Strasser A; Cory S
EMBO J; 1997 Aug; 16(15):4628-38. PubMed ID: 9303307
[TBL] [Abstract][Full Text] [Related]
2. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N
Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999
[TBL] [Abstract][Full Text] [Related]
3. Pore formation domain of human pro-apoptotic Bax induces mammalian apoptosis as well as bacterial death without antagonizing anti-apoptotic factors.
Ishibashi Y; Nishimaki K; Asoh S; Nanbu-Wakao R; Yamada T; Ohta S
Biochem Biophys Res Commun; 1998 Feb; 243(2):609-16. PubMed ID: 9480856
[TBL] [Abstract][Full Text] [Related]
4. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
[TBL] [Abstract][Full Text] [Related]
5. Expression of apoptosis and cell cycle related genes in proliferating and colcemid arrested cells of divergent lineage.
Gallaher BW; Berthold A; Klammt J; Knüpfer M; Kratzsch J; Bartsch M; Kiess W
Cell Mol Biol (Noisy-le-grand); 2000 Feb; 46(1):79-88. PubMed ID: 10726974
[TBL] [Abstract][Full Text] [Related]
6. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR
Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206
[TBL] [Abstract][Full Text] [Related]
7. p53 mediates bcl-2 phosphorylation and apoptosis via activation of the Cdc42/JNK1 pathway.
Thomas A; Giesler T; White E
Oncogene; 2000 Nov; 19(46):5259-69. PubMed ID: 11077443
[TBL] [Abstract][Full Text] [Related]
8. Bcl-x(S) can form homodimers and heterodimers and its apoptotic activity requires localization of Bcl-x(S) to the mitochondria and its BH3 and loop domains.
Lindenboim L; Borner C; Stein R
Cell Death Differ; 2001 Sep; 8(9):933-42. PubMed ID: 11526448
[TBL] [Abstract][Full Text] [Related]
9. Distinct domains of Bcl-XL are involved in Bax and Bad antagonism and in apoptosis inhibition.
Zhou H; Hou Q; Chai Y; Hsu YT
Exp Cell Res; 2005 Oct; 309(2):316-28. PubMed ID: 16061221
[TBL] [Abstract][Full Text] [Related]
10. Regulation of myeloid cell growth by distinct effectors of Ras.
Matsuguchi T; Kraft AS
Oncogene; 1998 Nov; 17(21):2701-9. PubMed ID: 9840934
[TBL] [Abstract][Full Text] [Related]
11. Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells.
Sawada M; Nakashima S; Banno Y; Yamakawa H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Nozawa Y
Oncogene; 2000 Jul; 19(31):3508-20. PubMed ID: 10918609
[TBL] [Abstract][Full Text] [Related]
12. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
[TBL] [Abstract][Full Text] [Related]
13. Pro- and anti-apoptotic members of the Bcl-2 family in skeletal muscle: a distinct role for Bcl-2 in later stages of myogenesis.
Dominov JA; Houlihan-Kawamoto CA; Swap CJ; Miller JB
Dev Dyn; 2001 Jan; 220(1):18-26. PubMed ID: 11146504
[TBL] [Abstract][Full Text] [Related]
14. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
[TBL] [Abstract][Full Text] [Related]
15. Induction and endoplasmic reticulum location of BIK/NBK in response to apoptotic signaling by E1A and p53.
Mathai JP; Germain M; Marcellus RC; Shore GC
Oncogene; 2002 Apr; 21(16):2534-44. PubMed ID: 11971188
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the molecular mechanisms for p53-mediated differentiation.
Chylicki K; Ehinger M; Svedberg H; Gullberg U
Cell Growth Differ; 2000 Nov; 11(11):561-71. PubMed ID: 11095245
[TBL] [Abstract][Full Text] [Related]
17. Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins.
Tang DG; Li L; Chopra DP; Porter AT
Cancer Res; 1998 Aug; 58(15):3466-79. PubMed ID: 9699682
[TBL] [Abstract][Full Text] [Related]
18. Triggering of apoptosis by Puma is determined by the threshold set by prosurvival Bcl-2 family proteins.
Callus BA; Moujallad DM; Silke J; Gerl R; Jabbour AM; Ekert PG; Vaux DL
J Mol Biol; 2008 Dec; 384(2):313-23. PubMed ID: 18835564
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Bax-sigma, a cell death-inducing isoform of Bax.
Schmitt E; Paquet C; Beauchemin M; Dever-Bertrand J; Bertrand R
Biochem Biophys Res Commun; 2000 Apr; 270(3):868-79. PubMed ID: 10772918
[TBL] [Abstract][Full Text] [Related]
20. Interaction of E1B 19K with Bax is required to block Bax-induced loss of mitochondrial membrane potential and apoptosis.
Han J; Modha D; White E
Oncogene; 1998 Dec; 17(23):2993-3005. PubMed ID: 9881701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
